Oscar Health Statistics
Total Valuation
Oscar Health has a market cap or net worth of $3.41 billion. The enterprise value is $1.15 billion.
| Market Cap | 3.41B |
| Enterprise Value | 1.15B |
Important Dates
The next confirmed earnings date is Tuesday, May 7, 2024, before market open.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Oscar Health has 194.21 million shares outstanding. The number of shares has increased by 4.32% in one year.
| Shares Outstanding | 194.21M |
| Shares Change (YoY) | +4.32% |
| Shares Change (QoQ) | +1.81% |
| Owned by Insiders (%) | 1.72% |
| Owned by Institutions (%) | 80.56% |
| Float | 171.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.58 |
| Forward PS | 0.40 |
| PB Ratio | 4.24 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.37.
| Current Ratio | 1.26 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.87 |
Financial Efficiency
Return on equity (ROE) is -30.10% and return on invested capital (ROIC) is -21.37%.
| Return on Equity (ROE) | -30.10% |
| Return on Assets (ROA) | -6.80% |
| Return on Capital (ROIC) | -21.37% |
| Revenue Per Employee | $2.44M |
| Profits Per Employee | -$112,803 |
| Employee Count | 2,400 |
| Asset Turnover | 1.47 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Oscar Health has paid $3.29 million in taxes.
| Income Tax | 3.29M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +200.17% in the last 52 weeks. The beta is 1.78, so Oscar Health's price volatility has been higher than the market average.
| Beta (1Y) | 1.78 |
| 52-Week Price Change | +200.17% |
| 50-Day Moving Average | 15.31 |
| 200-Day Moving Average | 9.83 |
| Relative Strength Index (RSI) | 67.30 |
| Average Volume (30 Days) | 3,129,416 |
Short Selling Information
The latest short interest is 7.66 million, so 3.94% of the outstanding shares have been sold short.
| Short Interest | 7.66M |
| Short Previous Month | 6.31M |
| Short % of Shares Out | 3.94% |
| Short % of Float | 4.48% |
| Short Ratio (days to cover) | 3.28 |
Income Statement
In the last 12 months, Oscar Health had revenue of $5.86 billion and -$270.73 million in losses. Loss per share was -$1.22.
| Revenue | 5.86B |
| Gross Profit | 394.83M |
| Operating Income | -235.62M |
| Pretax Income | -267.43M |
| Net Income | -270.73M |
| EBITDA | -212.14M |
| EBIT | -242.83M |
| Loss Per Share | -$1.22 |
Balance Sheet
The company has $2.56 billion in cash and $298.78 million in debt, giving a net cash position of $2.26 billion or $11.64 per share.
| Cash & Cash Equivalents | 2.56B |
| Total Debt | 298.78M |
| Net Cash | 2.26B |
| Net Cash Per Share | $11.64 |
| Equity / Book Value | 803.97M |
| Book Value Per Share | 4.14 |
| Working Capital | 632.09M |
Cash Flow
In the last 12 months, operating cash flow was -$272.16 million and capital expenditures -$25.58 million, giving a free cash flow of -$297.74 million.
| Operating Cash Flow | -272.16M |
| Capital Expenditures | -25.58M |
| Free Cash Flow | -297.74M |
| FCF Per Share | -$1.34 |
Margins
Gross margin is 6.73%, with operating and profit margins of -4.02% and -4.62%.
| Gross Margin | 6.73% |
| Operating Margin | -4.02% |
| Pretax Margin | -4.56% |
| Profit Margin | -4.62% |
| EBITDA Margin | -3.62% |
| EBIT Margin | -4.14% |
| FCF Margin | -5.08% |
Dividends & Yields
Oscar Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.32% |
| Shareholder Yield | -4.32% |
| Earnings Yield | -7.94% |
| FCF Yield | -8.73% |
Analyst Forecast
The average price target for Oscar Health is $12.82, which is -26.99% lower than the current price. The consensus rating is "Buy".
| Price Target | $12.82 |
| Price Target Difference | -26.99% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Oscar Health has an Altman Z-Score of 1.23 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.23 |
| Piotroski F-Score | 2 |